Mirxes

About Mirxes

MiRXES is a leading RNA technology company focused on early disease detection and precision medicine. Their mission is to deliver early, actionable, and personalized diagnoses across the care continuum to improve and save lives, with a strong emphasis on preventing late-stage cancer diagnoses through early detection and risk mitigation.

Products & Services

GASTROClear:A PCR-based in vitro diagnostic test for early detection of gastric (stomach) cancer.

LUNGClear:A diagnostic solution for lung cancer screening.

APEX Tissue:A tool for cancer treatment selection.

Fortitude 2.1:A diagnostic test for infectious diseases.

Swab & Saliva Collection:Tools for sample collection in diagnostic processes.

RNA Extraction Kits & Instruments:Kits and instruments for RNA extraction in research and diagnostics.

ID3EAL Suite:A technology suite for discovery solutions.

ID3EAL™ PanoramiR miRNA Knowledge Panel:A panel for miRNA knowledge in research applications.

Discovery Genomics:Genomics solutions for research purposes.

Cryomics:Solutions for biobanking and preservation.

Clinical Sequencing:Services for clinical genomics sequencing.

Specialties

RNA Technology Early Cancer Detection Precision Medicine Infectious Disease Diagnostics Genomics Molecular Testing

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Synthetic Royalty Financing T: - FT: Synthetic Royalty Financing	A: 40000000 MR: - FA: US$40 million FAN: 40000000	D: 2025-01-13 FD: 2025-01-13	1 investors

Synthetic Royalty Financing Latest

2025-01-13

$40.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

Z

Zhou Lihan

Executive Director, Co-founder & Chief Executive Officer

Z

Zou Ruiyang

Executive Director, Co-founder & Chief Technology Officer

I

Isaac Ho

Executive Director & Chief Investment Officer

C

Choo Beng Lor

Chief Financial Officer

V

Vitoria Owyong

General Counsel & Company Secretary

M

Martin Law

Managing Director, Hong Kong

View 10 more team members with Pro

Unlock Full Team Directory

Recent News

Mirxes Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised